Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection

Annals of Surgical Oncology
Wenwei ZhuLunxiu Qin

Abstract

Crosstalk between a tumor and the microenvironment plays a key role in tumor progression and metastasis. This study was performed to elucidate the prognostic significance of combining tumor-secreted osteopontin (OPN) with microenvironment-associated peritumoral macrophages (PTMs) in hepatocellular carcinoma (HCC), especially for those with early-stage disease. Tissue microarray-based immunohistochemistry was used to investigate OPN and PTMs expression in two independent cohorts consisting of 374 patients with HCC who underwent radical resection. The prognostic value for the two factors alone or in combination was investigated in these patients. OPN combined with PTMs was an independent prognostic factor for both overall survival (OS; p < 0.0001) and time to recurrence (TTR; p = 0.003) from the learning cohort (n = 96). Their combined value for prognosis was validated in early-stage HCCs using another independent cohort (n = 278; OS, p < 0.001; TTR, p = 0.001). This combination remained significant in HCCs with low α-fetoprotein levels in both cohorts, and was predictive for early recurrence/death risk (<2 years) compared with a single marker. Only OPN+HCCs had a significant correlation of PTMs levels with OS (p = 0.01) or TTR (...Continue Reading

References

Sep 1, 1996·Journal of Leukocyte Biology·E E RolloD T Denhardt
Dec 20, 2003·Journal of Cancer Research and Clinical Oncology·Zhao-You TangKang-Da Liu
Jan 7, 2004·Nature Reviews. Cancer·Jeffrey W Pollard
Jun 19, 2004·Journal of Cancer Research and Clinical Oncology·Lun-Xiu Qin, Zhao-You Tang
Dec 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeremy J W ChenPan-Chyr Yang
Oct 27, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN Practice Guidelines Committee, American Association for the Study of Liver Diseases
Jan 13, 2006·Trends in Cell Biology·Hema RangaswamiGopal C Kundu
Jun 1, 2006·Der Pathologe·C Wittekind
Dec 1, 2007·Cancer Metastasis Reviews·Philip Y Wai, Paul C Kuo
May 15, 2008·Journal of the National Cancer Institute·Josep M LlovetUNKNOWN Panel of Experts in HCC-Design Clinical Trials
May 30, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xiao-Dong ZhuHui-Chuan Sun
Jun 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xin-Rong YangZhao-You Tang
Oct 17, 2008·The New England Journal of Medicine·Morris Sherman
Oct 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Bing-Sheng SunLun-Xiu Qin
Sep 15, 2009·Journal of Hepatology·Jaw-Ching WuWing-Yiu Lui
Nov 3, 2009·The Lancet Oncology·Donald PoonUNKNOWN Asian Oncology Summit
Jul 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sandra S McAllister, Robert A Weinberg
Oct 5, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yu-Hua XueLun-Xiu Qin
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
May 7, 2011·Expert Reviews in Molecular Medicine·Susan R Rittling

❮ Previous
Next ❯

Citations

Mar 6, 2015·National Science Review·Pengyuan YangXiao-Fan Wang
Jan 6, 2016·Journal of Gastroenterology and Hepatology·Kazuto TajiriToshiro Sugiyama

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.